After I recently did well with 2 pharmaceutical/biotechnology stocks and the shares $NKTR (+0,44%) and also $GPCR went through the roof, yesterday I added a new $ARQT a new stock into my portfolio yesterday. They are also active in the dermatological field (neurodermatitis), but already have a sales driver on the market. Further approvals are to follow this year, which will lead to an expansion of the user groups.

This is therefore not a short-term trading position. I intend to hold it for a little longer.

In my view, last night's figures were very good. Let's see what the market makes of them today.

It always takes a little while until the auto import is carried out. First of all $GPCR has been stopped out. The profit is now clear. The first partial sale has already secured the stake and 25% profit.

With $GPCR I also feel very comfortable in the depot. I've already taken out the insert there.

Guggenheim left the rating for Structure Therapeutics ADR (NASDAQ: GPCR) at 'buy'. The target price is $140.00 after $90.00 previously.

Prior to this rating there were 15 analyst(s) that rated Structure Therapeutics ADR a 'Buy' and 0 rated it a 'Hold'. There were 0 Sell recommendations.

Analyst consensus estimates and price targets for Structure Therapeutics ADR can be found here. Further news on Structure Therapeutics ADR can be found here.

The Structure Therapeutics ADR share price ended the official trading session at a closing price of $88.64. The stock's performance was up 40.14% in the last month and up 212.77% in the last 12 months.

With $GPCR I also feel very comfortable in the depot. I've already taken out the insert there.

Guggenheim left the rating for Structure Therapeutics ADR (NASDAQ: GPCR) at 'buy'. The price target is $140.00 after $90.00 previously.

Prior to this rating there were 15 analyst(s) that rated Structure Therapeutics ADR a 'Buy' and 0 rated it a 'Hold'. There were 0 Sell recommendations.

Analyst consensus estimates and price targets for Structure Therapeutics ADR can be found here. Further news on Structure Therapeutics ADR can be found here.

The Structure Therapeutics ADR share price ended the official trading session at a closing price of $88.64. The stock's performance was up 40.14% in the last month and up 212.77% in the last 12 months.

Dear Community,

today I would like to talk to you about the curse and benefit of such a portal and why it helps me a lot to achieve my goals.

I often read about fomo or copy trades that people are tempted to make here. So today I would like to talk about how I think everyone can make use of the portal.

Of course you can get opinions here, discover pearls, because other users present them here analyzed in detail. And many people here also have specific goals. But for at least as many, the goals are not defined.

So why does the portal help me? I have very specific goals, not financial independence in 30 years or something like that. Everyone here knows my goal by now. And I have not only clearly defined the end goal, but also the path to get there, including the required return on investment and milestones. And of course, I've already talked about ideas like $RKLB (+3,35%) , $LMND (+1,31%) or even $GPCR have also benefited. But what really helps me the most is the transparency towards the community here that I have decided on. It disciplines me in my actions, I always and only pay attention to achieving the main and milestones. And because I always communicate all of this, I have even more incentive and discipline to make it work. I don't want to look like a visionary loser at some point. 😉😎That's why I'm going to keep it up and I won't turn tail if things don't work out. Because I'm sure some people here will have good ideas that I won't come up with.

And that's why I can only advise everyone, especially the younger ones here, to set concrete goals, even in stages, share them with the community and let us share in your successes and failures. I don't know of any other portal where there is as much concentrated knowledge about all asset classes as here, which is also gladly shared. And in the year I've been here, I've very, very seldom seen such gloating comments about failures.

And thank you also for your interest, your exchange, your reactions, which you show me again and again. It really supports my project.

So, that's it for today. I wish you all a great weekend.

Hello dear community, hello followers and, of course, anyone else who is interested. Here comes my review of 2025, which you've been waiting for so long. What has crazy Chris actually achieved?

Well, first of all, my monthly overview doesn't really look any different from that of many others here.

There were good and bad months. For me with 9 to 3 it was more positive than last year. The best and worst months in terms of returns were

January + 26.7%

September + 19%

April actually +14%

February - 12.8%

July - 6.6%

December -2.3%

Incidentally, January was also the best month last year and July and December were among the worst.

That reads rather harmlessly here. I would therefore like to show you what impact my strategy can have. At the start of my vacation on 01.09. I had a TTWROR of around 65%. This rose to 123% by mid-October and then fell back to 87% by mid-November. At the time of the GQ Rewind it was back to 99% as you can see above. This was of course disappointing as it was less than last year's 107%! But that is of course complaining at a very high level and not really meant seriously.

In €, and this is what most people here are interested in, it means the following.

Here are the facts that were already in part 2. the calculated target according to the original plan was

8,435 at the end of the calendar year 2025 (does not correspond to my investment year which ends on 31.03.).

13,340 was the multibagger target based on the performance of the previous year.

And this is the result as of today:

19.750,-- € a very good result in my opinion!

This means that as of today (yes, it is only a snapshot of my risk) I have already reached the calculated level for my project of € 3,000 to € 100,000 in 10 years by 31.03.2028, i.e. I have built up a buffer of a good 2.25 years. To be honest, I'm a bit proud of that.

You can disregard the total maturity figures you see in the chart, as I have only been tracking the portfolio with GQ since the beginning of 2025.

Next, I would like to tell you a bit more about how I achieved this outperformance. I have already explained my approach in Part 2.

Top trades were stocks:

$IREN (+6,04%) with +450% does not appear in Rewind because GQ only takes into account the stocks that are still in the portfolio at the time of creation.

$GPCR with + 188%

$PPTA (+3,35%) with + 160%

The flop 3 stocks were:

$BNTX (+0,86%) with - 20%

$IREN (+6,04%) with -19% after new purchase

$PATH (+1,24%) with -13%

all 3 loss positions are still running!

Now, of course, many people will think: And this is how he achieves such an excess return? Definitely not. As has already been mentioned several times, the majority of the excess return comes from the derivative trades. In my opinion, these returns cannot be achieved with shares over a period of 10 years. Of course, like me with $IREN (+6,04%) and some others, but that is the exception rather than the rule.

So now we come to the evaluation of the derivatives:

298 derivative trades were concluded.

Of these

11 x total loss

21 x greater than 100%

4 x greater than 200

2 x greater than 300%

The rest somewhere in between!

But to make you aware of the great risk, I have also taken the trouble to look up the holding period for the top returns. If you then extrapolate the returns achieved to 1 year, this often results in several 1000%!

This requires strong nerves, high leverage and the best possible entry time. So here are the pot flyers:

Derivative on €/SFR 390% in 48 days

United Health 320% in 4 days

Silver 280% in 21 days

App Lovin 216% in 2 days

Novo 186% in 3 days

Vossloh 170% in 6 days

Apple 185% in 13 days

Although the derivatives section only accounts for around a third of my portfolio, it is responsible for at least 60% of the performance.

Outlook for 2026

Calculated target 31.03.26 according to plan: € 9,145

Target multibagger 31.03.2026: € 22,000

Calculated target for calendar year 2026: € 12,230

Target multibagger 31.12.2026: € 29,000, because round figures are simply nicer, I would prefer 30,000, but let's not get cocky.

In addition to the pure figures, I see the following opportunities and risks in 2026. This is purely my subjective assessment, which I will also use as a basis for my investments. In my opinion, it will make sense to achieve a large part of the planned return in the first half of the year, as I see more opportunities there. Why? Because the effects of the new US interest rate and economic policy will not yet be as fully felt in the first half of the year as in the second half.

I therefore see good opportunities in the R-categories next year.

First and foremost commodities. Why? I believe that the escalation in the Caribbean will increase tensions between the USA and China again. The majority of Venezuelan oil exports go to China. The tightening of exports by China announced last week for silver, for example, will continue and rare earths will be the next to come back into play. The US will therefore continue to spend a lot of money to reduce its dependency, as otherwise it will be vulnerable to blackmail in all conflicts with China.

I therefore see great opportunities with $LYC (+3,58%) and also with $SSW (+2,14%) both of which I see as possible candidates for US entry.

But my price target of USD 5,000 for gold and above all my price target of USD 120-150 for silver in 2026 also offer excellent opportunities.

The next topic I see is armaments continues to be promising. Regardless of whether there will be peace in Ukraine. (I assume that the war will end soon if Ukraine is defeated) as there is a great danger that the USA will end its intelligence and satellite-based support. Donald Trump has elections next year and urgently needs successes.

However, an end to this war would not change the need for rearmament. The Europeans in particular are not even in a position to implement the security guarantees that are on the table. My best assessment here is in the area of drones and satellites.

I am also confident about data centers (also with their energy supply) and robotics.

As a longer-term tip, I would then focus on the biotechnology sector. For me, this is the area that has the greatest advantage through AI, as the evaluation of study data and thus the timeframe for approval will be massively accelerated. Some interesting candidates have already emerged here recently. For long-term ETF investors, this would also be worth considering.

Let us now turn to the overall economic outlook, which I expect. Even if it is said that political stock markets have short legs, this is more of a good opportunity for traders like me, as volatilities are rising.

I expect a very loose monetary policy in the USA. There will be significantly more than 1 interest rate hike and inflation will not play a role in the decisions. I strongly expect a yield curve control under the new Fed chief in the second half of the year. This will lead to a sharp fall in the US$. I think we will see an exchange rate of at least 1.25 to the euro in the course of the year. This is what the US government wants because it will make it more difficult for European countries, for example, to export to the US. I therefore anticipate below-average growth for export-oriented stocks in Europe. This trend will continue. The upcoming midterms in the USA in November will bring further uncertainty to the market in the second half of the year. There is a threat of a deadlock in the chambers. The foretaste of this will be felt again at the end of January when the next shutdown in the US threatens again.

Finally, I would like to mention a very important situation, which for me primarily affects Danish companies that have a high proportion of US business. First of all, I see the very popular $NOVO B (+0,12%) . In my opinion, there is a great danger that they will become a pawn in the battle for Greenland. Donald Trump will not go to war with Denmark, but maximum economic pressure to push through his wishes for a deal on Greenland seems very likely to me. In the end, Greenland will continue to belong to Denmark, but the USA will be granted extensive extraction rights there. Everyone should keep an eye on this and find out which US companies could benefit from exploiting the mineral resources there.

So that's it for the review and outlook from my point of view. Nobody knows whether this will happen.

Even if I will still be active here and comment a little, that's it for detailed posts. Of course, the evaluation of the Performance Challenge and the announcement of the winners will follow in the other post.

But to everyone I won't be speaking to, I'd like to wish you a happy new year 2026 with good health and, most importantly, as many personal highlights as possible. Don't forget that enjoying life can also be a great resolution.

With this in mind: All the best, Chris

I decided to pull out after the brilliant increase in $GPCR I decided to pull out the stake. Due to the very good performance, a sale of 25% was sufficient. I will let the other 75% continue to run.

Many thanks again to @Tenbagger2024 for the presentation. My wish for you for the New Year is that you implement more of your great discoveries more quickly yourself before they run away from you.

First of all, I would like to thank everyone who took the time to read through Part 1 and also the many positive reactions.

So, as promised, here is Part 2! Of course, it's already getting a bit more detailed. First of all, the conditions under which this project is running, as not everyone will have read all the previous posts. Those who already know can skip this section.

There are many people who have already raised this amount and many more. My challenge is that I want to achieve the whole thing in 10 years and without making any major deposits. This requires a net return of around 45% p.a. An almost unbelievable return, which would mean a significant outperformance of the market and a considerably higher risk. From this you can conclude that the saying: a burnt child shuns fire does not really apply to me in terms of risk.

Since some people are also interested in the mindset with which you approach such a project, I have to say that my own story described in Part 1 also helps me. If you have lived with debts in the millions, €3,000 is a fly in the ointment. I have no pressure to make this project a success. If I end up with 65, 75 or 80 TE, that's fine too. Even a total loss of the stake, which won't happen now unless there is a total loss of value due to war, etc., won't kill me. Total losses of individual trades are just as much a part of it as 100% and more.

Nevertheless, I am very consistent in my management with regard to maximizing returns, which often leads to quick sales and I don't give the value enough time to develop. In addition, my approach is very different from some other very successful investors here, such as @Tenbagger2024 who invests a lot of time in finding great companies for himself and the community, analyzing them (thank you very much for that), but then often waits for his analysis to be confirmed and the value then simply runs away from him too quickly, or @Epi the most analytical person I know, who checks everything three times, does backtests and then does great things like 3xGTAA as a wiki. @Liebesspieler who can analyze all the key figures and knows exactly what they mean and how to assign them. @EpsEra who puts a lot of work into very elaborate analyses to perfectly analyze entire areas with all the companies that are active there. And also @TomTurboInvest the chart technology fan. Many thanks to you and everyone else I have not mentioned by name for all the work you put in to bring added value to the community. Special thanks also go to those who have dared to write a post or an analysis for the first time in recent weeks and months. I now have over 2,600 members following me here, but very few of them dare to actively contribute something themselves. I can only say again and again, have the courage!

What do I do differently? I react faster, I often act intuitively. I don't analyze every last key figure. When I find an interesting company that I believe can achieve my high requirements of at least 5% price performance per month, I go for it. I don't wait for any confirmations, whether technical or numerical. As a result, I often pick up percentages that others leave behind. This often works, as was recently the case with $ONDS (+4,13%) ( first entry at 3.45$) or also at $GPCR but can of course also go wrong, as with $INT . That's part and parcel of betting primarily on small caps. For me, only the odds count. I don't have the ambition to find tenbaggers and hold the shares for so long. I prefer to take 200% or, as with $IREN (+6,04%) times 450%. I reinvest the money in other stocks and get back in when the time is right.

If I am wrong and the trend is going in the wrong direction right from the start, the stocks are quickly sold again. Sometimes too early, of course, and the boom comes later.

So what must the development be like and what has been achieved so far?

Start 01.04.2023 3.000€

Calculated target:

31.03.2024 = € 4,350 Real status € 5,200 Performance year 1 approx. 73%

Since GQ does not import historical data except for TR, you have to believe it or not.

31.12.2024 = € 5,355 Real value € 9,200

Best months in 2024: January, October and February

Worst months in 2024: December, July and April

Overall, I had a ratio of 7 months with a positive result and 5 with a negative result. This is another good example of how risk management works, as the positive months were naturally much more positive than the negative ones. So, as the old saying goes, the trick is to let profits run and hedge, and limit losses.

Calculated target 31.12.2025= 8435,--€

Target multibagger 31.12.2025 = € 13,340

You can see the result in Deep Dive Part 3! When the year is really over. Since this was the first year where I was at GQ and tracked all depots, there will also be screenshots and proven figures.

So that's it for part 2! Part 3 will follow at the end of the year with the conclusion of 2025! Wishing everyone a happy 4th Advent.

Feel free to ask questions in between and I look forward to every reaction and comment

After a 100% gain yesterday, analysts have been upgrading the shares of $GPCR high by the dozen. In the medium term, I also see a 3-digit price trend. But of course it depends very much on the phase 3 trial results. If they disappoint, the share price will not just fall by 20-30%.

Clear Street has left the rating for Structure Therapeutics ADR (NASDAQ: GPCR) to 'buy'. The price target is $99.00 after $61.00 previously.

Prior to this rating 14 analyst(s) rated Structure Therapeutics ADR as 'Buy' and 0 as 'Hold'. There were 0 Sell recommendations.

Analyst consensus estimates and price targets for Structure Therapeutics ADR can be found at hier. For more news on Structure Therapeutics ADR please visit hier.

The Structure Therapeutics ADR share price ended the official trading session at a closing price of $69.98. The stock's performance was up 106.43% in the last month and up 101.70% in the last 12 months.

BMO Capital has set the rating for Structure Therapeutics ADR (NASDAQ: GPCR) to 'outperform'. The price target is $130.00 after $100.00 previously.